Identification of Shared Genes and Pathways: A Comparative Study of Multiple Sclerosis Susceptibility, Severity and Response to Interferon Beta Treatment

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Mahurkar, Sunil ^a   Moldovan, Max ^b   Suppiah, Vijayaprakash ^a   O'Doherty, Catherine ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; PROTEIN TYROSINE KINASE;

ABL1 GENE; ARTICLE; DISEASE SEVERITY; DRUG RESPONSE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENOME ANALYSIS; GRB2 GENE; HUMAN; INPP5D GENE; KIF1B GENE; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PATHOGENESIS; PHENOTYPE; PIK3R1 GENE; PLCG1 GENE; PRKCD GENE; SIGNAL TRANSDUCTION; SRC GENE; TUBA1A GENE; TUBA4A GENE;

COMPUTATIONAL BIOLOGY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84874566776     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057655     Document Type: Article

References (59)

1. Alonso A, Hernán MA, (2008) Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurology 71: 129-135.
2. International Multiple Sclerosis Genetics Consortium, Hafler DA, Compston A, Sawcer S, Lander ES, et al. (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357: 851-862.
3. Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV, Broer L, Jafari N, et al. (2008) Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet 40: 1402-1403.
4. Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, et al. (2009) Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 18: 767-778.
5. De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, et al. (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 41: 776-782.
6. The Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Bahlo M, Booth DR, Broadley SA, Brown MA, Footeet SJ, et al (2009) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 41: 824-828.
7. Jakkula E, Leppä V, Sulonen AM, Varilo T, Kallio S, et al. (2010) Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 86: 285-291.
8. Nischwitz S, Cepok S, Kroner A, Wolf C, Knop M, et al. (2010) Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. J Neuroimmunol 227: 162-166.
9. Baranzini SE, Srinivasan R, Khankhanian P, Okuda DT, Nelson SJ, et al. (2010) Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. Brain 133: 2603-2611.
10. Wang JH, Pappas D, De Jager PL, Pelletier D, de Bakker PI, et al. (2011) Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data. Genome Med 3: 3.
11. The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer C, Nikolaos A et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219.
12. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, et al. (2000) The common PPAR[gamma] Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26: 76-80.
13. Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, et al. (2009) Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 18: 2078-2090.
14. Menon R, Farina C, (2011) Shared molecular and functional frameworks among five complex human disorders: A comparative study on interactomes linked to susceptibility Genes. PLoS ONE 6: e18660.
15. International Multiple Sclerosis Genetics Consortium, Briggs FB, Shao X, Goldstein BA, Oksenberg JR, Barcellos LF, et al. (2011) Genome-wide association study of severity in multiple sclerosis. Genes Immun 12: 615-625.
16. Byun E, Caillier SJ, Montalban X, Villoslada P, Fernández O, et al. (2008) Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis. Arch Neurol 65: 337-344.
17. Comabella M, Craig DW, Morcillo-Suárez C, Río J, Navarro A, et al. (2009) Genome-wide scan of 500 000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis. Arch Neurol 66: 972-978.
18. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362-9367.
19. Hu Z, Ng DM, Yamada T, Chen C, Kawashima S, et al. (2007) VisANT 3.0: new modules for pathway visualization, editing, prediction and construction. Nucleic Acids Res 35: W625-W632.
20. Rivals I, Personnaz L, Taing L, Potier MC, (2007) Enrichment or depletion of a GO category within a class of genes: which test? Bioinformatics 23: 401-407.
21. Chen J, Aronow BJ, Jegga AG, (2009) Disease candidate gene identification and prioritization using protein interaction networks. BMC Bioinformatics 10: 73.
22. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M, (2012) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 40: D109-D114.
23. Mosteller CF, Fisher RA, (1948) Questions and answers: Combining independent tests of significance. Am Stat 2: 30-31.
24. Cavanillas ML, Fernández O, Comabella M, Alcina A, Fedetz M, et al. (2011) Replication of top markers of a genome-wide association study in multiple sclerosis in Spain. Genes Immun 12: 110-115.
25. Cénit MD, Blanco-Kelly F, de las Heras V, Bartolomé M, de la Concha EG, et al. (2009) Glypican 5 is an interferon-beta response gene: a replication study. Mult Scler 15: 913-917.
26. Silberman I, Sionov RV, Zuckerman V, Haupt S, Goldberg Z, et al. (2008) T cell survival and function requires the c-Abl tyrosine kinase. Cell Cycle 7: 3847-3857.
27. Brightbill H, Schlissel MS, (2009) The effects of c-Abl mutation on developing B cell differentiation and survival. Int Immunol 21: 575-585.
28. Locke NR, Patterson SJ, Hamilton MJ, Sly LM, Krystal G, et al. (2009) SHIP regulates the reciprocal development of T regulatory and Th17 cells. J Immunol 183: 975-983.
29. Matejuk A, Hopke C, Dwyer J, Subramanian S, Jones RE, et al. (2003) CNS gene expression pattern associated with spontaneous experimental autoimmune encephalomyelitis. J Neurosci Res 73: 667-678.
30. Satoh JI, Tabunoki H, Yamamura T, (2009) Molecular network of the comprehensive multiple sclerosis brain-lesion proteome. Mult Scler 15: 531-541.
31. Lyons DA, Naylor SG, Scholze A, Talbot WS, (2009) Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons. Nat Genet 41: 854-858.
32. Jin H, Kanthasamy A, Anantharam V, Rana A, Kanthasamy AG, (2011) Transcriptional regulation of pro-apoptotic protein kinase Cδ. J Biol Chem 286: 19840-19859.
33. Kaul S, Kanthasamy A, Kitazawa M, Anantharam V, Kanthasamy AG, (2003) Caspase-3 dependent proteolytic activation of protein kinase Cδ mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: Relevance to oxidative stress in dopaminergic degeneration. Eur J Neurosci 18: 1387-1401.
34. Mero IL, Smestad C, Lie BA, Lorentzen ÅR, Sandvik L, et al. (2012) Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course. J Neuroimmunol 244: 107-110.
35. Blanco Y, Gómez-Choco M, Arostegui JL, Casanova B, Martínez-Rodríguez JE, et al. (2006) No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis. Neurosci Lett 396: 217-219.
36. Lindquist S, Schott BH, Ban M, Compston DA, Sawcer S, et al. (2005) The BDNF-Val66Met polymorphism: Implications for susceptibility to multiple sclerosis and severity of disease. J Neuroimmunol 167: 183-185.
37. Mirowska-Guzel D, Mach A, Gromadzka G, Czlonkowski A, Czlonkowska A, (2008) BDNF A196G and C270T gene polymorphisms and susceptibility to multiple sclerosis in the polish population. Gender differences. J Neuroimmunol 193: 170-172.
38. Lalive PH, Kantengwa S, Benkhoucha M, Juillard C, Chofflon M, (2008) Interferon-ß induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients. J Neuroimmunol 197: 147-151.
39. Yoshimura S, Ochi H, Isobe N, Matsushita T, Motomura K, et al. (2010) Altered production of brain-derived neurotrophic factor by peripheral blood immune cells in multiple sclerosis. Mult Scler 16: 1178-1188.
40. Blanco Y, Moral EA, Costa M, Gómez-Choco M, Torres-Peraza JF, et al. (2006) Effect of glatiramer acetate (Copaxone®) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: A longitudinal study. Neurosci Lett 406: 270-275.
41. Blanchette F, Neuhaus O, (2008) Glatiramer Acetate. J Neurol 255: 26-36.
42. Mabb AM, Ehlers MD, (2010) Ubiquitination in Postsynaptic Function and Plasticity. Annu Rev Cell Dev Biol 26: 179-210.
43. Seiwa C, Yamamoto M, Tanaka K, Fukutake M, Ueki T, et al. (2007) Restoration of FcRγ/Fyn signaling repairs central nervous system demyelination. J Neurosci Res 85: 954-966.
44. Laursen LS, Chan CW, Constant CF, (2009) An integrin-contactin complex regulates CNS myelination by differential Fyn phosphorylation. J Neurosci 29: 9174-9185.
45. Krämer-Albers EM, White R, (2011) From axon-glial signalling to myelination: The integrating role of oligodendroglial Fyn kinase. Cell Mol Life Sci 68: 2003-2012.
46. Gomez G, Gonzalez-Espinosa C, Odom S, Baez G, Cid ME, et al. (2005) Impaired FcεRI-dependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn deficiency in mast cells. J. Immunol 175: 7602-7610.
47. Ueda A, Zhou L, Stein PL, (2012) Fyn Promotes Th17 Differentiation by Regulating the Kinetics of RORγt and Foxp3 Expression. J Immunol 188: 5247-5256.
48. Jäger A, Kuchroo VK, (2010) Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol 72: 173-184.
49. Lee LF, Axtell R, Tu GH, Logronio K, Dilley J, et al. (2011) IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-β in multiple sclerosis. Sci Transl Med 3: 93ra68.
50. Miyamoto Y, Yamauchi J, Chan JR, Okada A, Tomooka Y, et al. (2007) Cdk5 regulates differentiation of oligodendrocyte precursor cells through the direct phosphorylation of paxillin. J Cell Sci 120: 4355-4366.
51. Vojtek AB, Taylor J, DeRuiter SL, Yu JY, Figueroa C, et al. (2003) Akt regulates basic helix-loop-helix transcription factor-coactivator complex formation and activity during neuronal differentiation. Mol Cell Biol. 23: 4417-4427.
52. Ingley E, (2012) Functions of the Lyn tyrosine kinase in health and disease. Cell Commun Signal 10: 21.
53. Baptista MS, Duarte CB, Maciel P, (2012) Role of the ubiquitin-proteasome system in nervous system function and disease: using C. elegans as a dissecting tool. Cell Mol Life Sci 69: 2691-2715.
54. Minagar A, Ma W, Zhang X, Wang X, Zhang K, et al. (2012) Plasma ubiquitin-proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b. Neurol Res 34: 611-618.
55. Lamkanfi M, Festjens N, Declercq W, Vanden Berghe T, Vandenabeele P, (2007) Caspases in cell survival, proliferation and differentiation. Cell Death Differ 14: 44-55.
56. Lorenz HM, Herrmann M, Winkler T, Gaipl U, Kalden JR, (2000) Role of apoptosis in autoimmunity. Apoptosis 5: 443-449.
57. Peterson JW, Bö L, Mörk S, Chang A, Trapp BD, (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50: 389-400.
58. Meyer R, Weissert R, Diem R, Storch MK, de Graaf KL, et al. (2001) Acute neuronal apoptosis in a rat model of multiple sclerosis. J Neurosci 21: 6214-6220.
59. O'Doherty C, Favorov A, Heggarty S, Graham C, Favorova O, et al. (2009) Genetic polymorphisms, their allele combinations and IFN-beta treatment response in Irish multiple sclerosis patients. Pharmacogenomics 10: 1177-86.